SYNTEX TICLID PATIENT COMPLIANCE PROGRAM OPERATED BY CSN
Executive Summary
SYNTEX TICLID PATIENT COMPLIANCE PROGRAM OPERATED BY CSN will pay pharmacists $6 upon enrollment of each patient, and $3 for each of three subsequent visits for "providing specific patient counseling" about Ticlid (ticlopidine), the Cognitive Service Network announced July 8. CSN, a joint venture between Zadox Health Care Corporation and General Computer Corporation, said that "over 500 pharmacies will participate in Florida, California and Ohio" in a three month pilot program on behalf of Syntex.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth